Mounjaro KwikPen
Slimming injection pen
€399.00
About Mounjaro
Mounjaro reduces appetite and promotes weight loss.
Used in conjunction with a healthy lifestyle.
Administration: Weekly injection under the skin.
Not suitable for patients with type 1 diabetes.
Side effects: Nausea and diarrhea are the most common.
Mounjaro is a medication that can help lower blood sugar and promote weight loss. It is used in adults with type 2 diabetes, but may also be helpful for overweight individuals who have difficulty losing weight despite a healthy lifestyle. Mounjaro decreases appetite, making it easier to reduce food intake. This medication is most effective when combined with a balanced diet, sufficient physical activity, and a healthy lifestyle. The effect varies from person to person: some see results quickly, while for others it takes longer. Mounjaro is available by prescription only and is administered by subcutaneous injection.
Each pen contains 4 doses. This medicine is available in several dosages. Each dosage is supplied in a package containing a pre-filled pen with disposable needles (1 pen = 4 doses).
Mounjaro contains tirzepatide, a substance that mimics the action of the body's natural hormones. These hormones help lower blood sugar by stimulating insulin release and decreasing appetite. Thus, Mounjaro can help stabilize blood sugar and potentially reduce body weight. This medication is most effective when combined with a healthy diet and regular physical activity.
The manufacturer of Mounjaro is:
Eli Lilly and Company
Indianapolis, IN 46285
USA
Mounjaro is administered once a week by injection under the skin, usually in the thigh, abdomen, or upper arm.
You can administer it at any time of day, with or without food.
Try to give yourself the injection on the same day each week.
Always follow your doctor's instructions regarding dosage.
If you are unsure how to inject, ask your doctor or pharmacist for help.
Mounjaro is safe for most people who are overweight and/or have type 2 diabetes.
Do not use if you are allergic to tirzepatide or any of the other ingredients.
Do not use if you have type 1 diabetes or diabetic ketoacidosis (a serious complication of diabetes).
Suitability during pregnancy and breastfeeding: see the dedicated section below.
There is no indication that Mounjaro affects driving, but be alert for symptoms such as dizziness.
Consult your doctor if you have serious gastrointestinal problems or a history of pancreatitis (inflammation of the pancreas).
Be careful if you suffer from serious gastrointestinal disorders, such as delayed gastric emptying.
Men: Pay particular attention if you have erectile dysfunction associated with diabetes, as fluctuations in blood sugar levels can have an impact.
Women: Weight loss can alter the menstrual cycle. Take this into account if you are using hormonal contraception.
Do not use Mounjaro if you are pregnant or planning to become pregnant. Stop at least two months before a planned pregnancy.
It is unknown whether Mounjaro passes into breast milk. Do not use it while breastfeeding.
Mounjaro can be used with other diabetes medications.
Be careful if you are using insulin or sulfonylureas (such as gliclazide), as the risk of hypoglycemia increases.
Consult your doctor if you are taking any other medications, especially if you have gastrointestinal problems.
Common (affecting more than 1 in 10 people): nausea, diarrhea, decreased appetite, vomiting, constipation.
Occasional (affecting 1 in 100 to 1 in 10 people): abdominal pain, indigestion, flatulence.
Rare (affecting less than 1 in 1,000 people): pancreatitis (inflammation of the pancreas), severe allergic reaction.
Mild side effects usually disappear over time.
Store Mounjaro in the refrigerator (2-8°C), do not freeze.
Protect it from light.
Keep it out of reach of children.
Once opened, the pen can be stored for up to 30 days at room temperature (maximum 30°C).